The specific aims of the Education Core are: 1) to integrate and create synergies between the pre-clinical and clinical investigators within MARC and between MARC investigators and other NIDA-funded centers;2) engage trainees in translational research by pairing pre-clinical trainees (NIDA/NIAAA training grant) with clinical investigators and clinical trainees (psychiatry residents and fellows) with pre-clinical investigators;3) design a career development program for MARC researchers to improve their communication, presentation and mentoring skills and an evaluation tool for measuring the program's impact;and 4) generate opportunites for the researchers to present their research findings to a national conference forum and to the public through community outreach and K-12 school education programs. The Education Core will coordinate with the academic units of the Departments of Behavioral Neuroscience and Psychiatry at the Oregon Health &Science University and of the Division of Mental Health and Clinical Neuroscience at the Veterans Administration Medical Center. The goals of the MARC support the health, education and community service missions of the University to promote healthy lifestyles and to improve science literacy of Oregon citizenry. The University has made a substantial commitment to establishing effective science education through its funding of the Science Outreach &Resources (SOAR) Committee and the Office of Science Education Opportunites. MARC researchers benefit from the wealth of opportunities to share their research findings with the public through one of the many campus'science education events including the Brain Awareness Week and Mental Health Week celebrations. The unique training combined with outreach opportunities gives every MARC researchers a chance to refine their communications skills and to more effectively disseminate their research findings.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA018165-05
Application #
8085771
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
5
Fiscal Year
2010
Total Cost
$72,940
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Shabani, Shkelzen; Schmidt, Bryan; Ghimire, Bikalpa et al. (2018) Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. Genes Brain Behav :e12533
Eshleman, Amy J; Nagarajan, Shanthi; Wolfrum, Katherine M et al. (2018) Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology (Berl) :
McCready, Holly; Kohno, Milky; Kolessar, Michael et al. (2018) Functional MRI and delay discounting in patients infected with hepatitis C. J Neurovirol 24:738-751
Loftis, Jennifer M; Valerio, Juno; Taylor, Jonathan et al. (2018) S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res :
Eshleman, Amy J; Wolfrum, Katherine M; Reed, John F et al. (2018) Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors. Biochem Pharmacol 158:27-34
Tosh, Dilip K; Ciancetta, Antonella; Mannes, Philip et al. (2018) Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 3:12658-12678
McCarty, Dennis; Priest, Kelsey C; Korthuis, P Todd (2018) Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annu Rev Public Health 39:525-541
Eastwood, Emily C; Eshleman, Amy J; Janowsky, Aaron et al. (2018) Verification of a genetic locus for methamphetamine intake and the impact of morphine. Mamm Genome 29:260-272
Kohno, Milky; Dennis, Laura E; McCready, Holly et al. (2018) A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder. Drug Alcohol Depend 192:186-192
Holton, Dwight; White, Elizabeth; McCarty, Dennis (2018) Public Health Policy Strategies to Address the Opioid Epidemic. Clin Pharmacol Ther 103:959-962

Showing the most recent 10 out of 143 publications